TEK and colorectal cancer: To further validate our results, we cultured MC38 and SW620 colorectal cancer cells with recombinant Ang1 for 24 h in the presence or absence of pharmacological inhibition of Tie2 (BAY-826) [30], followed by Western blotting to evaluate ARP2/3 expression.